Trial · NCT05487859
Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)
NCT05487859, Phase 2, Withdrawn, University of Alabama at Birmingham
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC). Trials, record NCT05487859. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05487859
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)
- NCT number
- NCT05487859
- Status
- Withdrawn
- Phases
- Phase 2
- Enrollment
- 0 participants, actual
- Lead sponsor
- University of Alabama at Birmingham
- Conditions
- Kidney Cancer
- Interventions
- Acarbose Tablets
- First posted
- 2022-08-04
- Last updated
- 2026-02-17
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | To assess the safety profile of acarbose in addition to standard of care (SOC) treatment in RCC | 2 years | adverse events will be defined and assessed using the National Cancer Institute's Common Terminology Criteria (CTCAE) v5.0 |
| Primary | To assess the effect of acarbose on the gut microbiome in patients receiving as standard of care therapy. | 2 years | Fecal microbiota populations will be characterized prior, during and after treatment with acarbose. |
| Secondary | To assess the efficacy of Acarbose in combination with SOC treatment in RCC | 2 years | Estimate of the median progression free survival (mPFS) of patients treated with SOC + Acarbose |
| Secondary | To assess the efficacy of Acarbose in combination with SOC treatment in RCC | 2 years | Estimate of the median overall survival (mOS) of patients treated with SOC + Acarbose |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05487859
GET https://conductscience.org/api/trials/v1/NCT05487859/registered